Specific binding of [3H]Ro 19-6327 (lazabemide) to monoamine oxidase B is increased in frontal cortex of suicide victims after controlling for age at death

European Neuropsychopharmacology

Volumn 18, Issue 1, 2008, Pages 55-61

  Ballesteros, Javier ^a   Maeztu, Ana I ^a   Callado, Luis F ^a   Meana, J Javier ^a   Gutiérrez, Miguel ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

Human brain; Lazabemide; MAO B; Monoamine oxidase; Ro 19 6327; Suicide

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; LAZABEMIDE; PSYCHOTROPIC AGENT; AMINE OXIDASE (FLAVIN CONTAINING); PICOLINIC ACID DERIVATIVE;

ADULT; ALCOHOLISM; ARTICLE; AUTOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BINDING; DRUG PROTEIN BINDING; FEMALE; FRONTAL CORTEX; HUMAN; MALE; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; AGING; BLOOD; ENZYMOLOGY; METABOLISM; MIDDLE AGED; PREFRONTAL CORTEX; PROTEIN BINDING; REGRESSION ANALYSIS; STATISTICAL MODEL; SUICIDE;

ADULT; AGING; ALCOHOLISM; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; MONOAMINE OXIDASE; PICOLINIC ACIDS; PREFRONTAL CORTEX; PROTEIN BINDING; PSYCHOTROPIC DRUGS; REGRESSION ANALYSIS; SUICIDE;

EID: 36749092848     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2007.05.001     Document Type: Article

References (39)

1. 2-imidazoline receptors and monoamine oxidase B enzyme sites in human brain: covariation with age. Neurosci. Lett. 288 (2000) 135-138
2. 3H]Ro 19-6327: a reversible ligand and affinity labeling probe for monoamine oxidase-B. Eur. J. Pharmacol. 162 (1989) 457-465
3. Coper H., Fahndrich E., Gebert A., Helmchen H., Honecker H., Muller-Oerlinghausen B., and Pietzcker A. Depression and monoamine oxidase. Prog. Neuro-Psychopharmacol. 3 (1979) 441-463
4. Crawley M.J. Statistical Computing. An Introduction to Data Analysis Using S-Plus (2002), John Wiley & Sons, Ltd, Chichester
5. Da Prada M., Kettler R., Keller H.H., Cesura A.M., Richards J.G., Saura J., Muggli-Maniglio D., Wyss P.C., Kyburz E., and Imhof R. From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors. J. Neural Transm., Suppl. 29 (1990) 279-292
6. Du L.S., Faludi G., Palkovits M., Sotonyi P., Bakish D., and Hrdina P.D. High activity-related allele of MAO-A gene associated with depressed suicide in males. NeuroReport 13 (2002) 1195-1198
7. Elliot J., Callingham B.A., and Sharman D.F. Semicarbazide-sensitive amine oxidase (SSAO) of the rat aorta. Interactions with some naturally occurring amines and their structural analogues. Biochem. Pharmacol. 38 (1989) 1507-1515
8. Fowler C.J., and Strolin-Benedetti M. The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimoxatone. J. Neurochem. 40 (1983) 1534-1541
9. Fowler C.J., Oreland L., Marcusson J., and Winblad B. Titration of human brain monoamine oxidase-A and -B by clorgyline and l-deprenyl. Naunyn-Schmiedeberg's Arch. Pharmacol. 311 (1980) 263-272
10. Fowler J.S., Volkow N.D., Wang G.J., Pappas N., Logan J., MacGregor R., Alexoff D., Shea C., Schlyer D., Wolf A.P., Warner D., Zezulkova I., and Cilento R. Inhibition of monoamine oxidase B in the brains of smokers. Nature 379 (1996) 733-736
11. Galva M.D., Bondiolotti G.P., Olasmaa M., and Picotti G.B. Effect of aging on lazabemide binding, monoamine-oxidase activity and monoamine metabolites in human frontal-cortex. J. Neural Transm. Gen. Sect. 101 (1995) 83-94
12. Georgotas A., McCue R.E., Friedman E., Hapworth W.E., Kim O.M., Cooper T.B., Chang I., and Stokes P.E. Relationship of platelet MAO activity to characteristics of major depressive illness. Psychiatry Res. 19 (1986) 247-256
13. Gottfries C.G., Oreland A., Wiberg A., and Winblad B. Lowered monoamine oxidase activity in brains from alcoholic suicides. J. Neurochem. 25 (1975) 667-673
14. Grote S.S., Moses S.G., Robins E., Hudgens R.W., and Croninger A.B. A study of selected catecholamine metabolizing enzymes: a comparison of depressive suicides and alcoholic suicides with controls. J. Neurochem. 23 (1974) 791-802
15. Henriot S., Kuhn C., Kettler R., and Da Prada M. Lazabemide (Ro 19-6327), a reversible and highly sensitive MAO-B inhibitor: preclinical and clinical findings. J. Neural Transm., Suppl. 41 (1994) 321-325
16. Kleinbaum D.G., Kupper L.L., Muller K.E., and Nizam A. Applied Regression Analysis and other Multivariable Methods. 3rd edn. (1998), Duxbury Press, Pacific Grove, CA
17. Klimek V., Roberson G., Stockmeier C.A., and Ordway G.A. Serotonin transporter and MAO-B levels in monoamine nuclei in the human brainstem are normal in major depression. J. Psychiatr. Res. 37 (2003) 387-397
18. Maeztu A.I., Ballesteros J., Callado L.F., Gutiérrez M., and Meana J.J. The density of monoamine oxidase B sites is not altered in the postmortem brain of alcoholics. Alcohol., Clin. Exp. Res. 21 (1997) 1479-1483
19. Manji H.K., Drevets W.C., and Charney D.S. The cellular neurobiology of depression. Nat. Med. 7 (2001) 541-547
20. Mann J.J., and Stanley M. Postmortem monoamine oxidase enzyme kinetics in the frontal cortex of suicide victims and controls. Acta Psychiatr. Scand. 69 (1984) 135-139
21. 2-adrenoceptors in the brain of suicide victims: increased receptor density associated with major depression. Biol. Psychiatry 31 (1992) 471-490
22. Miguel-Hidalgo J.J., and Rajkowska G. Comparison of prefrontal cell pathology between depression and alcohol dependence. J. Psychiatr. Res. 37 (2003) 411-420
23. Naoi M., Ishiki R., Nomura Y., Hasegawa S., and Nagatsu T. Quinolinic acid: an endogenous inhibitor specific for type B monoamine oxidase in human brain synaptosomes. Neurosci. Lett. 74 (1987) 232-236
24. Parsian A., and Todd R.D. Genetic association between monoamine oxidase and manic-depressive illness: comparison of relative risk and haplotype relative risk data. Am. J. Med. Genet. 74 (1997) 475-479
25. Puzynski S., Hauptmann M., and Zaluska M. Studies on biogenic amine metabolizing enzymes (DBH, COMT, MAO) and pathogenesis of affective illness. III. Platelet monoamine oxidase activity in endogenous depression. Acta Psychiatr. Scand. 67 (1983) 101-108
26. Reichborn-Kjennerud T., Lingjaerde O., and Oreland L. Platelet monoamine oxidase activity in patients with winter seasonal affective disorder. Psychiatry Res. 62 (1996) 273-280
27. Reveley M.A., Glover V., Sandler M., and Coppen A. Increased platelet monoamine oxidase activity in affective disorders. Psychopharmacology (Berl) 73 (1981) 257-260
28. 2 with monoamine oxidase-B sites. J. Neurochem. 61 (1993) 881-889
29. 2-adrenoceptors and monoamine oxidase B in brains of suicide victims. Neurochem. Int. 30 (1997) 63-72
30. 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs and human brain. J. Neurosci. 12 (1992) 1977-1999
31. Saura J., Bleuel Z., Ulrich J., Mendelowitsch A., Chen K., Shih J.C., Malherbe P., Da Prada M., and Richards J.G. Molecular neuroanatomy of human monoamine oxidases A and B revealed by quantitative enzyme radioautography and in situ hybridization histochemistry. Neuroscience 70 (1996) 755-774
32. Sherif F., Marcusson J., and Oreland L. Brain gamma-aminobutyrate transaminase and monoamine oxidase activities in suicide victims. Eur. Arch. Psychiatry Clin. Neurosci. 241 (1991) 139-144
33. Stockmeier C.A. Involvement of serotonin in depression: evidence from postmortem and imaging studies of serotonin receptors and the serotonin transporter. J. Psychiatr. Res. 37 (2003) 357-373
34. Tipton K.F., and Singer T.P. The radiochemical assay for monoamine oxidase activity. Problems and pitfalls. Biochem. Pharmacol. 46 (1993) 1311-1316
35. Tripodianakis J., Markianos M., Sarantidis D., Spyropoulou G., Taktikou V., and Bistolaki E. Platelet MAO activity in patients with dysthymic disorder. Psychiatry Res. 78 (1998) 173-178
36. Tripodianakis J., Markianos M., Sarantidis D., and Leotsakou C. Neurochemical variables in subjects with adjustment disorders after suicide attempts. Eur. Psychiatr. 15 (2000) 190-195
37. White K., Shih J., Fong T., Young H., Gelfand R., Boyd J., Simpson G., and Sloane R.B. Elevated platelet monoamine oxidase activity in patients with nonendogenous depression. Am. J. Psychiatry 137 (1980) 1258-1259
38. Whitfield J.B., Pang D., Bucholz K.K., Madden P.A., Heath A.C., Statham D.J., and Martin N.G. Monoamine oxidase: associations with alcohol dependence, smoking and other measures of psychopathology. Psychol. Med. 30 (2000) 443-454
39. Youdim M.B.H. The therapeutic potential of monoamine oxidase inhibitors. Nat. Neurosci. 7 (2006) 295-309